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KAJIAN ANTIBAKTERIA, ANTIOKSIDAN DAN ANTI-INFLAMASI 





Lygodium microphyllum merupakan paku pakis yang digunakan secara tradisi 
untuk mengawal cirit-birit berdarah, merawat bengkak dan penyakit kulit, meredakan 
sedu serta mengawal demam panas dan demam kepialu. Tujuan kajian ini adalah 
untuk menilai aktiviti antibakteria, antioksidan dan anti-inflamasi lima fraksi pelarut 
yang diperoleh daripada ekstrak mentah metanol daun paku pakis L. microphyllum 
secara pengekstrakan cecair-cecair dengan heksana, kloroform, etil asetat, n-butanol 
dan air. Analisis fitokimia dengan menggunakan kaedah ―Folin-Ciocalteu‖ dan 
kaedah kolorimetri aluminium klorida menunjukkan bahawa fraksi etil asetat 
mengandungi jumlah kandungan fenolik yang paling tinggi iaitu 11.59 ± 1.02 mg 
bersamaan sampel asid Gallic (GAE)/g, sementara itu fraksi heksana memaparkan 
jumlah kandungan flavonoid yang paling tinggi iaitu 60.27 ± 3.53 mg bersamaan 
sampel quercetin (QE)/g. Keputusan ini juga memperlihatkan bahawa sebatian 
fitokimia yang lain seperti alkaloid, glikosida, flavonoid, quinone, saponin dan 
steroid ditemui dalam fraksi heksana dan etil asetat, manakala tanin hanya terdapat 
dalam fraksi etil asetat. Kajian antibakteria yang dinilai melalui ujian in vitro 
antibakteria menggunakan kaedah mikropencairan medium broth menunjukkan 
bahawa fraksi etil asetat dan heksana mempamerkan aktiviti antibakteria yang tinggi 
terhadap semua bakteria enterik klinikal rintang yang diuji, iaitu, Escherichia coli, 
Klebsiella pneumonia, Proteus mirabilis, Salmonella typhi dan Shigella dysenteriae 




mempunyai nilai kepekatan perencatan minimum (MIC) dan kepekatan bakterisidal 
minimum (MBC) iaitu sebanyak 6.25 mg/mL dan 12.5 mg/mL. Aktiviti antioksidan 
yang ditentukan dengan menggunakan asai pemerangkapan radikal bebas DPPH, asai 
kuasa penurunan ferricyanide dan asai pelunturan β-karotena/asid linolik 
menunjukkan bahawa fraksi etil asetat mempunyai aktiviti tertinggi dalam kesemua 
asai. Sementara itu, kajian anti-inflamasi yang telah dijalankan menggunakan model 
inflamasi akut, iaitu, model tapak kaki belakang tikus aruhan karaginan 
menunjukkan bahawa fraksi heksana mempamerkan fraksi yang paling aktif dalam 
menghalang pembentukan edema. Kesimpulannya, keputusan keseluruhan  
menunjukkan bahawa paku pakis L. microphyllum adalah calon yang berpotensi 
untuk dikembangkan sebagai agen antibakteria, antioksidan dan anti-inflamasi untuk 
merawat jangkitan yang disebabkan oleh bakteria enterik, mengurangkan tekanan 











ANTIBACTERIAL, ANTIOXIDANT AND ANTI-INFLAMMATORY 





Lygodium microphyllum is a fern which has been used traditionally for 
controlling dysentery, treating swellings and skin diseases, curing hiccups as well as 
controlling high fever and typhoid fever. The aim of the study was to evaluate the 
antibacterial, antioxidant and anti-inflammatory activities of five solvent fractions 
obtained from crude methanol extract of L. microphyllum leaves by liquid-liquid 
extraction of hexane, chloroform, ethyl acetate, n-butanol and water. Phytochemical 
analysis via Folin-Ciocalteu's method and aluminium chloride colorimetric method 
showed that ethyl acetate fraction obtained the highest total phenolic content of 11.59 
± 1.02 mg gallic acid equivalents (GAE)/g sample, whereas hexane fraction 
displayed the highest total flavonoid content of 60.27 ± 3.53 mg quercetin 
equivalents (QE)/g sample. The results also revealed that other phytochemical 
compounds such as alkaloid, glycosides, flavonoids, quinones, saponin and steroid 
were found in hexane and ethyl acetate fractions, whilst tannins were found only in 
the ethyl acetate fraction. The antibacterial study assessed via in vitro antibacterial 
test using broth microdilution method showed that ethyl acetate and hexane fractions 
displayed potent antibacterial activity against all tested clinically resistant enteric 
bacteria, namely, Escherichia coli, Klebsiella pneumonia, Proteus mirabilis, 
Salmonella typhi and Shigella dysenteriae as well as the control strain isolate 
Escherichia coli (ATCC 25922) with minimum inhibitory concentration (MIC) and 




respectively. The antioxidant activity determined via DPPH free radical scavenging 
assay, ferricyanide reducing power assay and β-carotene/linoleic acid bleaching 
assay showed that ethyl acetate fraction had the highest activity in all assays. 
Meanwhile, in the anti-inflammatory study, which was carried out using acute 
inflammatory model, i.e., carrageenan-induced rat hind paw oedema model showed 
that hexane fraction exhibited the most active fraction in inhibiting the oedema 
formation. In conclusion, the results indicated that L. microphyllum is a potential 
candidate to be developed as an antibacterial, antioxidant and anti-inflammatory 
agent for the treatment of enteric infection, minimizing the oxidative stress in human 






CHAPTER 1  
INTRODUCTION 
In recent years, interests on the screening and development of new drugs for 
pharmacological effects including anti-malarial, anti-parasitic, anti-angiogenic, anti-
bacterial, anti-inflammatory, anti-diabetic and anti-cancer from plant-based products 
especially medicinal plants have been studied worldwide. Bioactive compounds that 
exhibit pharmacological properties from plants have been extracted, separated, 
isolated and identified continuously today in myriad ways (Sasidharan et al., 2011; 
Azmir et al., 2013). The isolated bioactive compounds for therapeutic purposes are 
known as plant-derived drugs and have been used for millennia to cure various 
human diseases including infectious diseases.  
Infectious diseases involve two factors which are pathogen and human host. 
Pathogen agent refers to microorganisms and mostly pathogenic to vulnerable host 
like human. People around the globe are suffering from infectious diseases caused by 
a wide range of pathogens, including bacteria (tuberculosis, leprosy, and diarrhea), 
virus (Human immunodeficiency virus (HIV) and Zika virus) and parasite (malaria). 
Reactive oxygen species (ROS) is generated from either endogenous (infections and 
various inflammatory processes) or exogenous source (produce in response to 
ultraviolet (UV) radiation due to global warming) which contributed in elevating 
levels of ROS. Disruption of normal cellular homeostasis by redox signaling 
contributes to disease in virtually every organ including the development of cancer. 
Factors likes global warming and unpredictable climate changes across the century 




diseases worldwide. Consequently, the changes of the survival, reproduction and life 
cycle of microorganisms particularly bacteria through environmental stress have 
occurred. Therefore, not surprisingly, the impact of extreme climate changes like El 
Nino, La Nina, flood and drought were being followed by the outbreak of various 
infectious diseases around the world (Wu et al., 2016). The uncontrolled outbreaks of 
many infectious diseases in developing countries are due to financial restraint and 
shortage of medical resources, and have become worst after the emergence of drug-
resistant particularly in the 21st century.  
Morbidity and mortality amongst humans due to infectious diseases caused by 
pathogenic microorganisms such as bacterial infection particularly gram-negative 
bacteria have increased. Since the discovery of penicillin and its beneficial healing 
effect in multiple infectious diseases, mankind is fully depended upon it and have 
extensively used the antibiotic as treatment against all kinds of bacterial infections. 
On the contrary, bacteria has increased their ability to prevent the antibiotic binding 
to their targets by means of activating the efflux pumps, enzymatic inactivation of 
antibiotic, and altering of their targets site. Subsequently, the bacteria has managed to 
develop resistance to antibiotics, thereby declining the effectiveness of available 
antibiotics against the targeted bacteria and resulting in the human life-threatening 
infections worldwide (Bhatt et al., 2015).  
Enteric bacteria are representative of gram-negative bacteria and known as bacterial 
gastroenteritis from family Enterobacteriaceae. Habitually, enteric bacteria are 
capable of triggering infection of the intestinal tract causing diarrhea and dehydration 
mostly in young children (Petri et al., 2008). Enteric bacteria like Escherichia coli, 
Shigella sp. and Salmonella sp. are able to colonize and disrupt intestinal function 




clinical concerns on their resistance to antibacterial agents especially E. coli, in 
which this enteric infection will end up in treatment failure. No new relevant 
compounds of drugs have been developed mainly to combat the emergence of 
antibiotic-resistance in bacteria particularly the gram-negative enteric bacteria 
(Zabawa et al., 2016). Therefore, the development of new antibiotics able to treat 
infections caused by enteric bacteria, which cover a broad range of antibiotics 
inhibiting the target of these bacteria is seriously needed.  
Natural products have been recognized as source of therapeutic agents against 
bacterial infectious diseases. Natural sources from plants are attracting attention 
globally as potential sources of antibacterial agents (Taylor, 2013). Nowadays, the 
discovery and development of compounds from the plant kingdom which possess 
activity against pathogenic bacteria have been explored extensively. Therefore, plant-
based products are candidates to be studied to defeat drug-resistance enteric bacteria. 
Human diseases caused by adverse effects of oxidative stress have become a serious 
problem nowadays. Oxidative stress is the situation when there is an imbalance of 
number between the reactive oxygen species (ROS) and antioxidant available in the 
body. Normally, the amount of ROS surpasses the normal level, disturb and damage 
the cells, finally give problems to our health. This imbalance creates an antioxidant 
deficiency environment and may lead to various diseases, namely, Alzheimer‘s 
disease, Parkinson‘s disease, rheumatoid disease, heart disease, eye disease, cancer 
and inflammatory disorders. Natural product, namely, plant-based product can play a 
crucial role to overcome diseases caused by ROS. According to Krishnaiah et al. 
(2011), increasing the level of antioxidant in the body by consuming supplement diet 
from antioxidant compounds found in plant products is the best solution to prevent 




reaction of ROS in damaged tissues by terminating the radical chain reactions, 
thereby decreasing the incidence of human diseases. Therefore, in this study the 
antioxidant activity of Lygodium microphyllum extracts was explored. 
The emergence of various diseases nowadays are caused by the infection of pathogen 
and the effects of oxidative stress resulting from the reaction of ROS, whereby these 
factors have a strong correlation with inflammation. Inflammation is believed to be a 
protective mechanism of the body to eradicate the hazardous stimuli such as morbific 
pathogens, damaged tissues caused by ROS and also irritants as well as promoting 
the healing process of the affected tissues by restoring back their normal function and 
structure. The eradication failure of the hazardous stimuli by immune system can 
lead to chronic inflammation. Autoimmune diseases such as rheumatoid arthritis, 
Crohn's disease, lupus, Type 1 diabetes and Addison‘s disease are examples of 
chronic inflammations due to persistent attack of leukocytes to healthy and 
unaffected tissues (Ehlers & Kaufmann, 2010; Franceschi & Campisi, 2014). 
Therefore, it is important to protect our tissues from damage and gain back the 
normal tissue functions, and at the same time reduces the potency of the illness 
getting worse. 
Steroids and non-steroidal anti-inflammatory drugs (NSAIDs) are the common drugs 
used worldwide for the treatment of inflammation. Unfortunately, these type of drugs 
possess side effects for example corticosteroids causes inherent insufficiency of 
adrenal (Alves et al., 2008), and aspirin contributes to gastrointestinal problems 
(Laine, 2003). Due to the side effects; there is now an urgent need to develop new 
anti-inflammatory agents from natural plant-based which are believed to have less 




Almost all classes of plants play an important role in the development of potent 
therapeutic agents. Pteridophytes, the non-flowering primitive vascular plants, have 
also been found to be utilized as traditional medicines of the Chinese (Cao et al., 
2015), Indian (Talukdar & Talukdar, 2013) and Native American (Karadeniz et al., 
2015). Secondary metabolites are produced by all species of plants including fern for 
the purpose of defending themselves against environmental stress in order to adapt to 
their environment (Mazid et al., 2011). Ferns existing on earth for millions of years 
have survived and successfully adapted along with the environmental stressess due to 
climate changes. Therefore, there is a belief that ferns consist more functional 
bioactive compounds that exhibit various pharmacological effects compared to 
flowering vascular plants (Lee & Shin, 2011).  
Lygodium microphyllum (Schizaeaceae) is one of the ferns which has important 
contributions for prevention and treatment of various human ailments. Studies of the 
fern leaf decoction have revealed its effects on the control of dysentery, as poultices 
for skin diseases and swellings, and curing of hiccups (Benniamin, 2011). The Malay 
old folks have been using these fern leaves to control high fever and typhoid fever. 
Unfortunately, to date, no comparative studies have been reported on the 
pharmacological effects of this fern, primarily in Malaysia.  
Hence, based on the abundance of L. microphyllum in Malaysian ecosystem, and its 
potential as therapeutic agents, the current research was undertaken to explore the 
potential pharmacological activities of L. microphyllum leaves extracts as an 
antibacterial, antioxidant and anti-inflammatory agent. In addition to these, the 
bioactive activities of the crude methanol L. microphyllum extract and its fractions 
may give us ideas for better understanding the correlation of the chemical 





The current study was conducted with the following objectives: 
i. To evaluate the Malaysian fern crude methanol L. microphyllum extract and 
its fractions as potential anti-bacterial against enteric bacteria and perform the 
phytochemical analysis.  
ii. To identify the antioxidant activities of the crude methanol L. microphyllum 
extract and its fractions. 
iii. To investigate the effectiveness of crude methanol L. microphyllum extract 












CHAPTER 2  
LITERATURE REVIEW 
2.1  Overviews of infectious diseases 
Relationships between host and pathogenic bacteria are complex and dynamic. The 
host such as humans are infected when bacteria are invade, growing and multiplying 
within the human body. Additionally, many pathogenic bacteria have specialized 
strategy, i.e., entry into human cells and tissues for survival and multiplication. The 
nature of an infection is varied and based on the severity, location (appropriate 
environment within the host, e.g., nutrient, temperature, and pH) and the number of 
pathogens invading and multiplying to produce an infection. Examples of various 
types of infection associated with pathogenic bacteria are bacteremia (a condition of 
viable bacteria present in the blood), septicemia (blood poisoning associated with 
persistence of bacteria and their toxin in the blood), localized (the infections are 
restricted to a limited or certain anatomical regions) and abscess (a localized 
infection with a collection pus surrounded by inflamed area) (Prescott et al., 2008).  
An unhealthy state is a condition of any part of the human body that are not capable 
of doing their normal functions due to the presence of bacteria or its products, is 
described as a phenomena of infectious disease. Generally, the end result of the 
relationship between host and bacteria is dependent on the degree of pathogenicity or 
virulence of the bacteria, the number of invading bacteria to the host as well as the 
degree of host‘s defenses (Wilson et al., 2002).  
Pathogenic bacteria has at least one reservoir which is a place to live and multiply. 




bacteria. Initial vehicle of the pathogenic bacteria to the reservoir (or host) such as 
human is a vital feature in the development of infectious diseases. Bacteria can be 
transmitted via direct contact which is from human to human by sneezing and 
coughing; besides, bacteria is also able to transmit indirectly by various ways. For 
examples, infected humans spread bacteria into their surroundings, and then the 
bacteria deposited on various surfaces which indirectly transmitted to other humans 
or resuspended into the air. In addition, soil, water and food also play a role in 
transmitting the bacteria to humans indirectly (Girard et al., 2006). 
After being transmitted to the human, bacteria must be able to adhere to and colonize 
cells or tissues. Pathogenic bacteria can penetrate epithelial surface via passive 
mechanisms such as ulcers or injury in a mucous membrane, wounds or burns on the 
skin‘s surface, tissue damage as well as from the cellular internalization pathways of 
human which are phagocytosis and endocytosis (Prescott et al., 2008; Kim et al., 
2012). Generally, pathogenic bacteria attached to the epithelial surface, and then 
penetrate the human‘s mucous membranes and epithelium. Bacterial pathogen likely 
to penetrate deeper into the tissues and spread to all organs and tissues through the 
production of specific virulence factors which consist of enzymes or bacterial‘s 
product assist the dissemination and subsequently entering the small terminal 
lymphatic capillaries that surrounded the epithelial cells. Consequently, the bacteria 
successfully reached the whole system and damage the circulatory system; thus, the 
final determinant of a successful bacterial pathogen is its capability of leaving the 
human and invading other human or reservoirs (Prescott et al., 2008). Typically, the 
pathogenic bacteria leave human via urine, feces, droplets, or saliva, and then 




Bacterial pathogen can contaminate food and water, and thus causing human 
infections such as acute gastroenteritis, which is an infection that involved in 
inflammation of the stomach and intestinal lining. Gastroenteritis can occur in two 
ways. The first way, the pathogenic bacteria colonized gastrointestinal and multiply 
within it, and then invades human tissues or release exotoxins. The second way, the 
exotoxin released by the pathogenic bacteria may contaminate food, that consumed 
by humans. Food contaminated with bacterial pathogen may produce a food-borne 
infection and the condition often referred as food poisoning. Meanwhile, food 
contaminated by bacterial‘s products is referred to food intoxication and the 
condition referred to as enterotoxin poisoning. Enterotoxin is released by several 
bacterial pathogens and the targets are intestines. Toxin secreted by the bacterial 
pathogen impeded the function of the intestinal mucosa by altering permeability 
apical membrane of the mucosa cells of the intestinal wall and then kills the cells, 
thus consequently leads to show symptoms of gastrointestinal infection, viz., 
vomiting, nausea, abdominal pain, and diarrhea. 
2.2 Diarrheal disease 
The major health problem nowadays is diarrheal disease. Diarrhea is one of the 
symptoms and indicative of gastrointestinal infections, which can be caused by 
various bacterial pathogens such as enteric bacteria (Godana, 2013; Karambu et al., 
2013). Additionally, diarrheal disease lead morbidity and mortality particularly 
among young children around the world (WHO/UNICEF, 2013). Diarrheal infection 
disseminated through various ways, either from contaminated food or water; or 




According to Godana (2013), clinical types of diarrhea can be divided into three, i.e., 
acute watery diarrhea, acute bloody diarrhea (dysentery) and persistent/chronic 
diarrhea. However, duration and severity of diarrhea are different between each type 
of diarrhea, of which the sign and symptom of acute diarrhea are watery diarrhea and 
bloody diarrhea lasts no longer than two weeks; meanwhiles, the episode of diarrhea 
of persistent/chronic diarrhea lasts longer than two weeks. In addition, the clinical 
types of diarrhea also lean on its particular causes and the sources. Therefore, 
following patient‘s historical descriptions such as the presence of associated enteric 
symptoms; history of food ingestion, camping, and travelling; as well as animal 
exposure may help to recognize the causes or sources of the patient‘s diarrhea. 
Normally, mild watery diarrhea, a condition of not showing the symptom of fever or 
bloody feces is associated with non-invasive enteropathogens; whereas, severe 
watery diarrhea, which shows enteric symptoms often linked to the presence of 
enteric bacterial pathogens, i.e., enterotoxigenic E. coli (ETEC) (Kumar et al., 2015). 
Meanwhile, bloody diarrhea (dysentery) which showed enteric symptoms, bloody 
feces and the microscopic presence of red and white blood cells in the stool sample is 
caused by enteropathogens such as bacterial pathogens from the genera Salmonella, 
Shigella, Yersinia and Campylobacter that attack intestinal tract (Chowdhury et al., 
2010).  
Dehydration is the most severe threat during diarrhea episode. Dehydration occurs 
when water as well as electrolytes such as potassium, chloride and sodium, which 
lost via liquid stools, sweat, urine and vomit are not replaced. Severe dehydration 
may occur if the water and electrolytes are not replenished; thus, severe dehydration 
often followed by death. Zinc supplements are proven life-saving of young children 




problem of young children always associated with zinc deficiency and during 
diarrhea, zinc also loses through dehydration process (Sazawal et al., 1995; Shimelis 
et al., 2008). Therefore, use of zinc supplements with oral rehydration salts (ORS) 
reduces morbidity and mortality of diarrhea disease particularly infants and younger 
age children (WHO/UNICEF, 2013).  
2.3 Enteric bacteria (Enterobacteriacae) 
Enteric bacteria are bacteria in the family Enterobacteriaceae, a large family of 
gram-negative bacteria and consist of 44 genera which constituent the genera that 
can be characterized by recognizing the metabolic properties of this family. The 
morphology of Enterobacteriaceae is rod-shaped bacterial with simple nutritional 
requirement, peritrichously flagellated or nonmotile, non spore-forming and have 0.3 
- 1.0 X 1.0 - 1.06 µm of cell dimensions. Most members of Enterobacteriaceae are 
facultative anaerobes and chemoorganotrophs, which exhibit both respiratory and 
fermentative metabolism. The representative genera of this family are Escherichia, 
Salmonella, Shigella, Citrobacter, Klebsiella, Proteus, Enterobacter, Erwinia, 
Serratia and Yersinia.  Several genera of this family possess vital human pathogens 
responsible for causing various diseases.  
Members of Enterobacteriaceae are so common and often called as enteric bacteria 
which reside normally in the intestines of humans including animals. Based on their 
ability to cause diarrheal disease of humans, Enterobacteriaceae can be divided into 
a group of pathogens and non-pathogens. However, the most pathogenic genera of 
this family are Salmonella and Shigella as well as some strains of Escherichia. In 
contrast, members of Enterobacteriaceae which possessed minimum pathogenicity 




strains have gained access to the other tissues sites or when the host, such as human 
is immunocompromised. Examples of opportunistic infections caused by 
opportunistic Enterobacteriaceae are respiratory tract infections, wound infections 
and urinary tract infections. Normally, the  genus of Klebsiella, Proteus, Citrobacter, 
Enterobacter, Serratia, Morganella and Providencia are referred to as opportunistic 
Enterobacteriaceae (Prescott et al., 2008).  
2.3.1 Escherichia coli infections 
The large intestine has the highest microbial population in the body and Escherichia 
coli is a common member regularly found in the large intestine. Eventhough, 
majority of E. coli strains are non-pathogenic members of the normal intestinal flora, 
but some strains may cause diarrheal disease by several mechanisms thus, E. coli is 
often known as an essential food-borne pathogen. The strains of E. coli which 
associated with gastrointestinal disease, including diarrheal disease are classified into 
common strains, i.e., consist of Enteropathogenic Escherichia coli (EPEC), 
Enterotoxigenic Escherichia coli (ETEC) and Enterohaemorrhagic Escherichia coli 
(EHEC); and rare strains of pathogenic E. coli which was isolated from young 
children with diarrhea, i.e., Enteroaggregative Escherichia coli (EAggEC) and 
Enteroinvasive Escherichia coli (EIEC).  
EPEC is an important cause of diarrhea in children residing in developing countries. 
This strain attaches to the epithelial cells, multiplying and causing cell damage called 
effacing lesions, thereby causing vomiting, fever and prolonged diarrhea mainly in 
infants less than 5 years. ETEC is often referred to as traveler‘s diarrhea, which is 
responsible for watery diarrhea due to production of plasmid-mediated toxins, 




adults. EHEC causes life-threatening haemorrhagic colitis with severe abdominal 
pain and cramps followed by bloody diarrhea in all ages and frequently without 
fever. This infection occurs by ingesting contaminated meat and dairy products, as 
well as unpasteurized milk. E .coli 0157: H7, which carry the genes for Shiga-like 
toxin is a major form of EHEC. Shiga-like toxin (Stx-1 and STX-2 proteins) is able 
to kill vascular endothelial cells, which are detected by the bacteriophage-encoded 
genetic of this bacterial strain, have also been involved in the extra-intestinal disease, 
which is haemolytic uraemic syndrome that leads to renal failure (Nguyen & 
Sperandio, 2012).  
EAggEC causes chronic watery diarrhea and vomiting, mainly in children. This 
strain adheres to epithelial cells in localized regions, forming clumps of bacteria with 
the appearance of brick-like (aggregates). Meanwhile, EIEC strains causes dysentery, 
fever and colitis, with mucus, blood and present of many pus cells in feces. The 
ability of this strain to invade intestinal epithelial cells by penetrating and 
multiplying in cells is associated with the presence of a large plasmid. It is believed 
that this strain may also produce an enterotoxin and cytotoxin (Prescott et al., 2008) 
2.3.2 Salmonellosis 
Salmonellosis is referred to as Salmonella gastroenteritis can be caused by many 
Salmonella serovar (serological variation or strains). Typically, in developing 
countries, Typhimurium and Enteritidis are frequently isolated serovars from human. 
Salmonellae are aerobes and facultative anaerobes; besides, they are gram negative, 
motile, and non-sporing rods. Human acquired the infection by ingesting 




of animals and human sources. Common sources of infection are beef and beef 
products, poultry, egg and egg products and water.  
The incubation time of Salmonellae in the body is around 8 to 48 hours. Once the 
Salmonellae is in the body, they multiplied and invaded the intestinal mucosa which 
subsequently produced enterotoxin and cytotoxin to destroy the epithelial cells. Thus, 
symptoms such as diarrhea, fever, vomiting, abdominal pain and cramps as well as 
nausea may occur within 12 to 36 hours after ingesting infected food. Normally, 
these prominent symptoms persist up to 5 days, but able to last for several weeks. In 
acute infection diarrhea diseases, blood and mucus appear in feces as well as 
abundant Salmonella shed in the feces. Usually, patients like infants, elderly and 
immunosuppressed persons are at higher risk of loss of fluids in the body due to 
diarrhea, thereby increasing the rate of mortality especially among infants. Besides 
diarrheal disease, food-poisoning Salmonella strains can also cause bacteraemia, 
septicaemia and inflammation of the gall bladder (Sánchez-Vargas et al., 2011).  
2.3.3 Typhoid fever 
Typhoid fever, is the most serious form of disease, caused by Salmonella enterica 
serovar Typhi (Salmonella Typhi) and is acquired by ingestion of water 
contaminated with feces of infected human. Meanwhile, paratyphoid fever, a milder 
form of the disease, is caused by Salmonella enterica subspecies enterica serovars 
Paratyphi A, B and C (Salmonella Paratyphi A, B and C) and is acquired by 
ingestion of food contaminated with these strains. Infection caused by S. typhi among 
children and young adults (less than 19 years) is a major public health concern in 
developing countries. Furthermore, untreated typhoid fever may result in death 




Generally, the incubation period of the bacteria after entering the small intestine is 
about 10 to 14 days. The bacteria will colonize the small intestine, then invade the 
epithelium and spread to the blood, gall bladder, liver and lymphoid tissue. The 
noticeable symptoms of this infection including headache, fever, abdominal pain, 
anorexia and malaise, which persist up to several weeks. However, once the bacteria 
reinfected the gastrointestinal tract, the prominent symptoms, i.e., diarrhea and rash 
(rose spot) appeared (Sánchez-Vargas et al., 2011). Paratyphoid fever caused by S. 
paratyphi A, B and C has symptoms similar to typhoid fever, however, the infection 
of this strains tends to be milder and has lower mortality rate (Girard et al., 2006). 
2.4 Antibacterial activity 
2.4.1 Antibacterial agent 
In the 21st century, modern medicine is dependent on chemical agents or 
chemotherapeutic agents that are used to treat many infectious diseases in order to 
destroy pathogenic organisms or inhibit their growth. Pathogenic organisms residing 
in the human bodies can cause disease, thus the control and immediate destruction of 
the pathogenic agents is important. Mostly, infectious diseases caused by pathogenic 
agents are treated with antibiotics which is chemotherapeutic agents at the minimum 
concentration that enough to treat infections without harming the host.  
Drugs, which kill or inhibit microbial pathogen are variable according to their range 
of effectiveness. Broad-spectrum drugs that effective for many types of pathogens 
(such as aerobic and anaerobic organisms; gram-negative and gram-positive 
bacteria). Meanwhile, narrow-spectrum drugs are effective only against specified 




antibacterial, antifungal, antiprotozoal and antiviral based on their actions against 
bacterial, fungi, protozoa and virus, respectively. Generally, the term of antibiotic is 
used to describe antimicrobial agents, but usually refers to antibiotic agents. 
Antibiotic are classified into natural (produced and isolated from bacterial and mold), 
semi-synthetic (modified chemically from natural antibiotics) and synthetic 
(manufactured by chemical procedures without microbial activity) drugs that can 
destroy susceptible pathogens or inhibit their growth. Most semi-synthetic drugs 
have a broad-spectrum of antibacterial activity compared to their parent constituent. 
Antibiotics can be either bactericidal or bacteriostatic. Those that kill the target 
bacteria are bactericidal agents, however, their activity depends on the concentration 
that may be at low concentration and exhibit bacteriostatic action. Whereas, those 
reversibly inhibit growth are referred as bacteriostatic agents. Nevertheless, if the 
agents is removed, the bacteria will grow again (Prescott et al., 2008).  
Antibiotics can be grouped according to their mechanism of action, e.g., cell wall 
synthesis inhibition, protein synthesis inhibition and nucleic acid synthesis inhibition. 
Tetracycline is a family of antibiotics with a common four-ring structure of which a 
variety of side chains are attached. This antibiotic is related to antibacterial agent that 
inhibit bacterial protein synthesis by binding to the bacterial ribosome, and combined 
with 30 S (small) subunit of the ribosome. Thus, inhibits the binding of aminoacyl-
tRNA molecules to the ‗A‘ site of the ribosomal acceptor. The effectiveness of 
treatment using this antibiotic depends on active host resistance to the pathogen since 
their action is bacteriostatic. In addition, tetracyclines are broad-spectrum antibiotic 
that are used actively against gram-negative and gram-positive bacteria. Common 
side effects of tetracyclines include gastrointestinal disturbance, renal injury and 




them attractive for use in the treatment of bacterial infections (Chopra and Roberts, 
2001; Eliopoulos et al., 2003).  
2.4.2 Antibacterial resistance 
In the 21st century, the spread of drug-resistant bacteria is a growing worldwide 
problem. Infectious diseases are difficult to treat because of the antibacterial 
resistance due to intensive use and misuse of available antibiotics. Common 
mechanisms of resistant bacteria to survive doses of antibiotics that would previously 
exhibit bactericidal effects are due to the production of enzymes which inactivate or 
modify antibiotic, modify the target site and changes in the bacterial cell membrane, 
thereby preventing the uptake of antibiotic. Resistant bacteria undergo genetic 
change, which may occur by mutation process or by the acquisition of new genetic 
material (Wilson et al., 2002). 
Since the turn of this century, the world is interested in combating multi-drug 
resistant (MDR) bacteria mainly in the gram-positive bacteria like methicillin-
resistant Staphylococcus (MRSA) and vancomycin-resistant enterococci (VRE). 
Many efforts have been done by researchers and drug companies to develop new 
compounds. Giske et al. (2008) reported antibiotics, such as linezolid and 
daptomycin which are able to fight these bacteria. Unfortunately, during the world 
fight with infections caused by antibiotic-resistance gram-positive bacteria strain, 
gram-negative bacteria take placed and become dominant; thus, diseases caused by 
them become a serious problem nowadays. According to Bhatt et al. (2015), 
previously, drug-resistant gram-negative bacteria was initially threatened as 
nosocomial bacteria that spread the infections within environment of health-care 




reported. Furthermore, no new compounds of drugs are currently developed solely to 
treat infections caused by antibiotic-resistant gram-negative bacteria. 
Antibiotic resistance also increased rapidly in health care facility like hospital due to 
overuse or misuse of antibiotic. The extensive growth of antimicrobial resistance by 
pathogens sooner or later will be limiting the life span of common antibiotic. 
Consequently, new effective antibiotics are urgently needed to combat resistance 
bacteria. The pharmaceutical drug such as carbapenems and polymyaxin have been 
used as the last resort against multidrug-resistant gram-negative bacteria, and has 
become as first-line therapy after all other options of antibiotic proved ineffective 
(Walsh & Amyes, 2004; de Oliveira et al., 2015). However, the utilization of these 
drugs has been limited due to appearance of carbapenem-resistant bacteria and the 
toxicity concerning polymyxin. Antibiotic resistant continuously grow and spread 
rapidly from time to time exceeding the number of discovery and development of 
new anti-resistant antibiotics. Therefore, the intensive research and development of 
new antibacterial drugs from natural sources are urgently needed in the present 
situation. 
2.4.3 Evaluation of antibacterial susceptibility test 
In the treatment and control of infectious diseases, susceptibility testing is used to 
determine the effectiveness of antibacterial against specific pathogens. Besides, 
susceptibility testing can give an estimation of proper therapeutic dose of 
antibacterial agents for further treatment. Laboratory antibacterial susceptibility 
testing can be performed using dilution susceptibility and disk diffusion tests. 
Dilution susceptibility test is a manual or semi-automated dilution techniques to 




to determine the minimum bactericidal concentration (MBC) which measures the 
lowest concentration of antibacterial needed to kill bacteria. A dilution test can be 
done in both agar and broth media, but broth dilution is the most commonly used 
method to determine the antibacterial susceptibility (Balouiri et al., 2016) .  
A twofold dilution is carried out by diluting the concentrated tested antibacterial 
stock solution. Then, a standardized inoculum of the test organism is added and 
incubated overnight. After incubation, the lowest concentration of diluted tested 
antibacterial required to prevent visible growth, which refer to MIC is reported 
(CLSI, 2016). The MBC can be assessed if the broth showing no visible growth is 
subcultured into fresh medium. The lowest antibiotic concentration from which the 
bacteria do not grow when subcultured to agar medium is the MBC value. Broth 
microdilution represent the performance of the broth dilution test in microdilution 
plates with a capacity of less than or equal to 400 µL per well. In addition, 
microdilution procedure is believed to produce fast and reliable quantitative result of 
MIC (Nijs et al., 2003; Balouiri et al., 2016) 
2.5 Antioxidant activity 
2.5.1 Antioxidant agents 
Reactive Oxygen Species (ROS) is referred to as reactive molecules and free radicals 
derived from oxygen. The oxygen based radicals is an unstable molecule, where the 
unpaired electron can shift or paired with other electrons. Reactive molecules can be 
termed as active oxygen species, where it is generated after our system in the body 




(Yoshikawa and Naito, 2002). Examples of active oxygen species are superoxide 
radical, hydrogen peroxide, hydroxyl radical, hydroxyl ion and nitric oxide.  
Respiratory burst, a condition of increased in oxygen consumption due to phagocytes 
ingest bacteria has occurred in the tissues and resulting in production of ROS such as 
superoxide and hydrogen peroxide (Rada & Leto, 2008). ROS molecules are 
antibacterial and toxic to bacteria. The degradation of bacteria via oxygen-dependent 
degradation depended on the molecules of ROS including hydroxyl radicals and 
singlet oxygen, which able to kill the bacteria (Robinson, 2008; Petropoulos et al., 
2015). 
The protective agent to counteract oxidative stress, which is referred to as antioxidant 
prevents and repairs the damage caused by ROS particularly free radicals, thereby 
enhancing the immune defense and depleting risk of chronic diseases to human body. 
ROS at high concentration is harmful to human tissue by subjecting the tissue to the 
deleterious process and damaging the cell; whereas, ROS at low concentration is 
beneficial especially in cellular and immune responses (Pham-Huy et al., 2008). 
Antioxidants are able to quench the free radicals from the reactive oxygen-based 
radicals (ROS-based radicals). The endogenous antioxidants present in our body are 
divided into two functional groups - the enzymatic antioxidants (e.g., primary 
enzymes: superoxide dismutase, glutathione peroxidase and catalase) and the non-
enzymatic antioxidants (e.g., Vitamin A, uric acid, coenzyme Q10, and glutathione), 
which are responsible to inhibit the production of free radicals or able to neutralize 
the free radicals of ROS-based radicals (Carocho & Ferreira, 2013). Antioxidant 
deficiencies in our body can occur when the endogenous antioxidant system is 




antioxidant compounds such as Vitamin C, Vitamin E, Vitamin K, phenolic acids, 
flavonoids, β-carotene and some minerals. These can be taken in naturally 
particularly from plant-based products, and via diets to balance the concentration of 
free radical production in our body.  
Endogenous and exogenous antioxidants have a synergistic effect to prevent the 
debut of oxidative stress. Nevertheless, the concentration of exogenous antioxidants 
should be controlled to prevent them from turning to pro-oxidant agents (Bouayed & 
Bohn, 2010; Carocho & Ferreira, 2013). Despite its ability to display pro-oxidant 
activity, the exogenous antioxidants from plant-based products are receiving great 
attention to overcome diseases caused by ROS. Thus, the demand of using natural 
antioxidants from plant sources in the pharmaceutical, nutraceutical and cosmetic 
products has increased worldwide (Singh et al., 2013). Furthermore, synthetic 
antioxidants like propyl gallate, butylated hydroxytoluene (BHT) and butylated 
hydroxyanisole (BHA), which are used as additives in food industries have 
controversial issues on their adverse effects on human health due to its carcinogenic 
potentials (Krishnaiah et al., 2011; Carocho & Ferreira, 2013). Consequently, 
demand of using of plant-based antioxidant products, particularly in the food 
industry has increased.  
Plants have a self-defense system to protect the cells from damage due to abiotic and 
biotic stresses. The defense system consists of enzymatic and non-enzymatic 
antioxidants such as superoxide dismutase, ascorbate peroxidase, phenolic acids, 
flavonoids, and carotenoid (Hossain et al., 2007; Lee & Shin, 2011). These 
antioxidant compounds play an important role in human defense system since our 
body needs these sources of exogenous antioxidants from plant products to help 




2.6 Anti-inflammatory activity 
2.6.1 Overview of inflammation and anti-inflammatory 
Human is continuously exposed to pathogenic bacteria and their metabolic products 
that can cause diseases. However, human has an immune system that protects them 
from adverse effects consequences of this exposure. Immune system consists of cells, 
tissues and organs that recognize the intrusion of foreign materials into the body. 
Immune system has also the capability to mobilize defense cells and cell products to 
help neutralize or destroy a particular foreign material speedily and effectively. 
Immunity is categorized as innate (nonspecific immune response) and adaptive 
immunity (specific immunity). 
Innate immunity is also refers to the body‘s natural ability to recognize and destroy 
foreign materials. The components of innate immunity are (a) mechanical methods 
which prevents the entry of microbes into the body or physically remove them from 
the body surface, (b) chemical mediator - acts directly against foreign materials or 
that activates other mechanisms, leading to the destruction of foreign materials, (c) 
cells - phagocytise the production of chemicals involved in the immune system 
response and (d) inflammation - mobilises the immune system and isolates foreign 
materials until they can be destroyed. There are general mechanisms inherited as part 
of the innate function and acts as a first line defense. Innate immunity is a 
nonspecific immune response defends against foreign substances equally but has no 
immunological memory (Serhan, 2008).  
Infection, activation of the immune system, inflammation response and ischemia are 




radicals and non-radicals (oxidants). The imbalance between production and 
neutralization of ROS (including nitric oxide) in human tissues leads to oxidative 
stress, thereby resulting the oxidative damage tissue associated with the occurrence 
of numerous diseases including inflammatory disorders.  
Inflammation is an important nonspecific defense reaction to hazardous stimuli such 
as pathogenic invader, damaged cells and also irritants. Acute inflammation is the 
immediate response of the body to hazardous stimuli. Resident cells of the human 
tissue consist of monocytes, macrophages, dendritic cells and Kupffer cells, which 
have receptors known as pattern recognition receptors (PRRs), responsible to 
recognize pathogen-associated molecular patterns (PAMPs) and damage-associated 
molecular patterns (DAMPs). PAMPs are products derived from pathogens that are 
able to interact with PRRs; whereas, DAMPs are chemical factors released by 
damaged or injured tissue that are able to bind to PRRs (Rubartelli & Lotze, 2007; 
Srikrishna & Freeze, 2009). After the activation of PRRs by binding either to PAMPs 
or DAMPs, these resident cells (e.g., macrophages) released inflammatory mediators 
and activate the immune response (Tang et al., 2012).   
For example, when there is an invading agent such as pathogenic bacteria invades 
human tissue, the body tries to destroy that agent by activating a cascade of events 
including (a) activation of specific immune cells, (b) release of chemical mediators 
from these active cells, and (c) increased infiltration of phagocytes in response to the 
chemical mediators, that result in the development of the signs of inflammation 
which causes pain, redness, sweeling, heat and loss of function in the affected area 
(Ryan & Majno, 1977; Ward & Lentsch, 1999). The symptom or sign may appear for 
a few days, then, inflammation has three possibilities whether fully recover, develops 




diseases results from acute inflammation, including acute bronchitis, acute 
appendicitis, acute dermatitis, acute infective meningitis and acute tonsillitis. 
However, if the inflammation is not controlled, it may lead to tissues damage, 
fibrosis and necrosis.   
In general, eliminating any hazardous stimuli is the main target of the innate immune 
response, and if necessary, aided by the adaptive immune response. Failure to 
eliminate the hazardous stimuli or inefficient termination of the inflammatory 
response, could lead to chronic inflammation. Therefore, inflammatory process 
should be well regulated by the immune system to avoid tissue damage.  
An adequate treatment of acute inflammation becomes compulsory to protect any 
tissue damage, restore the tissue structure and function, as well as to turn off the 
inflammatory response after eliminating the hazardous stimuli. This is to prevent 
overproduction of the pro-inflammatory cytokine [interleukin (IL)-1β, IL-6, tumor 
necrosis factor (TNF)-α, and chemokines] and inflammatory mediators (including 
ROS and NO) that will likely perpetuate immune reaction and tissue damage 
(Kanterman et al., 2012).  
Conventional anti-inflammatory drugs, namely steroids and non-steroidal anti-
inflammatory drugs (NSAIDs) have been used until now to treat inflammation, 
especially acute inflammatory disorders; however, currently used steroids and 
NSAIDs are associated with bad side effects (e.g., diarrhea, kidney and liver 
failures). The discovery of new anti-inflammatory compounds of plant sources have 
received great attention from researchers especially in academia and pharmaceutical 
industry due to few side effects (Fürst & Zündorf, 2014). 
